The Nuclear Factor Erythroid 2–Related Factor 2 Activator Oltipraz Attenuates Chronic Hypoxia–Induced Cardiopulmonary Alterations in Mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Nuclear Factor Erythroid 2–Related Factor 2 Activator Oltipraz Attenuates Chronic Hypoxia–Induced Cardiopulmonary Alterations in Mice
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Volume 49, Issue 2, Pages 324-333
Publisher
American Thoracic Society
Online
2013-05-23
DOI
10.1165/rcmb.2011-0396oc
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Deletion of Nrf2 Impairs Lung Development and Oxidant Injury in Neonatal Mice
- (2012) Hye-Youn Cho et al. ANTIOXIDANTS & REDOX SIGNALING
- Retrograde heart perfusion: The Langendorff technique of isolated heart perfusion
- (2011) Robert M. Bell et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Nrf2-regulated PPARγ Expression Is Critical to Protection against Acute Lung Injury in Mice
- (2010) Hye-Youn Cho et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Discovery of the Negative Regulator of Nrf2, Keap1: A Historical Overview
- (2010) Ken Itoh et al. ANTIOXIDANTS & REDOX SIGNALING
- Pulmonary Hypertension in COPD: Epidemiology, Significance, and Management
- (2010) Omar A. Minai et al. CHEST
- Oltipraz upregulates the nuclear respiratory factor 2 alpha subunit (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice
- (2010) Z. Yu et al. DIABETOLOGIA
- Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1
- (2010) K. Taguchi et al. MOLECULAR AND CELLULAR BIOLOGY
- Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction
- (2009) Roshan P. Weerackody et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- HIF-1 Induction Attenuates Nrf2-Dependent IL-8 Expression in Human Endothelial Cells
- (2009) Agnieszka Loboda et al. ANTIOXIDANTS & REDOX SIGNALING
- Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress
- (2009) Jinqing Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Age-Accelerated Atherosclerosis Correlates With Failure to Upregulate Antioxidant Genes
- (2009) Alan R. Collins et al. CIRCULATION RESEARCH
- The Nrf2 Activator Oltipraz Also Activates the Constitutive Androstane Receptor
- (2008) M. D. Merrell et al. DRUG METABOLISM AND DISPOSITION
- MafG controls the hypoxic response of cells by accumulating HIF-1α in the nuclei
- (2008) Koji Ueda et al. FEBS LETTERS
- Dithiolethiones for cancer chemoprevention: where do we stand?
- (2008) Y. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice
- (2008) T. E. Sussan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema
- (2008) D Goven et al. THORAX
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search